ATE129152T1 - Zusammensetzungen von maillard-reaktion inhibitoren. - Google Patents

Zusammensetzungen von maillard-reaktion inhibitoren.

Info

Publication number
ATE129152T1
ATE129152T1 AT91903819T AT91903819T ATE129152T1 AT E129152 T1 ATE129152 T1 AT E129152T1 AT 91903819 T AT91903819 T AT 91903819T AT 91903819 T AT91903819 T AT 91903819T AT E129152 T1 ATE129152 T1 AT E129152T1
Authority
AT
Austria
Prior art keywords
maillard reaction
disease
pharmaceutically acceptable
compositions
ester
Prior art date
Application number
AT91903819T
Other languages
English (en)
Inventor
Jun Inoue
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE129152T1 publication Critical patent/ATE129152T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
AT91903819T 1990-02-19 1991-02-08 Zusammensetzungen von maillard-reaktion inhibitoren. ATE129152T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP3924190 1990-02-19

Publications (1)

Publication Number Publication Date
ATE129152T1 true ATE129152T1 (de) 1995-11-15

Family

ID=12547636

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91903819T ATE129152T1 (de) 1990-02-19 1991-02-08 Zusammensetzungen von maillard-reaktion inhibitoren.

Country Status (7)

Country Link
EP (1) EP0474874B1 (de)
KR (1) KR920700632A (de)
AT (1) ATE129152T1 (de)
CA (1) CA2049940C (de)
DE (1) DE69113938T2 (de)
ES (1) ES2078509T3 (de)
WO (1) WO1991011997A1 (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2288732B (en) * 1994-04-13 1998-04-29 Quadrant Holdings Cambridge Pharmaceutical compositions
US6290991B1 (en) 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6740668B1 (en) 1995-08-28 2004-05-25 Kansas University Medical Center Methods for inhibiting diabetic complications
US6228858B1 (en) 1995-09-12 2001-05-08 University Of Kansas Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6716858B1 (en) 1995-08-28 2004-04-06 Kansas University Medical Center Methods for inhibiting diabetic complications
US6750209B1 (en) 1995-09-12 2004-06-15 Kansas University Medical Center Advanced glycation end-product intermediaries and post-amadori inhibition
US6730686B1 (en) 1995-09-12 2004-05-04 Kansas University Medical Center Methods for inhibiting oxidative modification of proteins
US5744451A (en) 1995-09-12 1998-04-28 Warner-Lambert Company N-substituted glutamic acid derivatives with interleukin-1 β converting enzyme inhibitory activity
GB9602444D0 (en) * 1996-02-07 1996-04-03 Chege Joseph Pharmaceutical compositions for the prevention or treatment of retrovirus infections
US7030146B2 (en) 1996-09-10 2006-04-18 University Of South Carolina Methods for treating diabetic neuropathy
US5741926A (en) * 1997-02-12 1998-04-21 Shaman Pharmaceuticals, Inc. Aniline derivatives having antihyperglycemic activity
US20060165606A1 (en) 1997-09-29 2006-07-27 Nektar Therapeutics Pulmonary delivery particles comprising water insoluble or crystalline active agents
US6565885B1 (en) 1997-09-29 2003-05-20 Inhale Therapeutic Systems, Inc. Methods of spray drying pharmaceutical compositions
US6919326B1 (en) 1998-08-24 2005-07-19 Toshio Miyata Carbonyl-stress improving agent and peritoneal dialysate
WO2000021516A2 (en) * 1998-10-14 2000-04-20 Kansas University Medical Center Research Institute, Inc. Methods for inhibiting diabetic complications
DE69908630T2 (de) * 1998-10-22 2004-04-29 University Of South Carolina Verfahren zur hemmung von diabetischen komplikationen
WO2000059493A2 (en) * 1999-04-06 2000-10-12 Kansas University Medical Center Improved dialysis solutions and methods
US8404217B2 (en) 2000-05-10 2013-03-26 Novartis Ag Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
US7871598B1 (en) 2000-05-10 2011-01-18 Novartis Ag Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
TWI290473B (en) 2000-05-10 2007-12-01 Alliance Pharma Phospholipid-based powders for drug delivery
WO2003053411A1 (en) 2001-12-19 2003-07-03 Nektar Therapeutics Pulmonary delivery of aminoglycosides
JP4739705B2 (ja) * 2004-07-21 2011-08-03 ロート製薬株式会社 内服用組成物
BRPI0514827A (pt) * 2004-09-01 2008-06-24 Procter & Gamble composições compreendendo ácido 5-amino-2hidróxi- benzóico e açúcar redutor
JP5725599B2 (ja) * 2010-04-26 2015-05-27 池田食研株式会社 抗酸化性組成物の製造方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS567747A (en) * 1979-06-25 1981-01-27 May & Baker Ltd Acylaminobenzoic acid derivative

Also Published As

Publication number Publication date
EP0474874B1 (de) 1995-10-18
WO1991011997A1 (fr) 1991-08-22
EP0474874A4 (en) 1992-08-19
KR920700632A (ko) 1992-08-10
DE69113938D1 (de) 1995-11-23
CA2049940C (en) 1996-03-05
EP0474874A1 (de) 1992-03-18
ES2078509T3 (es) 1995-12-16
DE69113938T2 (de) 1996-04-11

Similar Documents

Publication Publication Date Title
ATE129152T1 (de) Zusammensetzungen von maillard-reaktion inhibitoren.
DK0842161T3 (da) 4,5-diaryl-oxazol-derivater
ATE157870T1 (de) Ophthalmische zusammensetzung enthaltend ein 1,5- benzoxathiepin-derivat zur behandlung von glaukoma
PL290758A1 (en) Method of obtaining novel heterocyclene compounds
DK0604657T3 (da) Phosphonsyrediesterderivat
DE69406323D1 (de) Substituierte Aminsäure Derivate verwendbar für die Behandlung von Arteriosclerosis
NO179746C (no) 1-aryloksy-3-alkylamino-2-propanolnitratestere, deres anvendelse og tilsvarende farmasöytiske blanding
DE69006178T2 (de) 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol-derivate.
ATE88634T1 (de) Arzneimittel zur behandlung von herzinsuffizienz.
DE69411852T2 (de) Indolderivate, ihre Salze und sie enthaltende Arzneimittel zur Behandlung von Herzkrankheiten
DE69021525D1 (de) Pyrrolaldehydderivate.
ATE212842T1 (de) Quinoxalin-derivate zur behandlung von tinnitus
DE68907232T2 (de) Indanoxyessigsäure-Derivate und Verfahren zu deren Herstellung.
NO960777L (no) Anvendelse av N-alkylerte 1,4-dihydropyridin dikarboksylsyreestere som medikamenter
DE69417957D1 (de) Chinolin-3-essigsäure-derivate, verfahren zu deren herstellung und anwendung
JPS57134471A (en) Novel sydnonimine derivative, its preparation, and drug containing said derivative as active component
DK0437645T3 (da) Imidazolylpropylguanidinderivat, fremgangsmåde til fremstilling deraf og lægemidler indeholdende denne forbindelse

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties